biote Corp.

biote Corp. (Nasdaq: BTMD) is a healthcare company focused on hormone optimization that completed its business combination with Haymaker Acquisition Corp. III, a blank-check vehicle sponsored by Haymaker Sponsor III, LLC, in 2022. The company, which provides bioidentical hormone replacement therapy through a pellet-based delivery model serving a network of physician practices across the United States, filed its S-1 registration statement with the SEC on August 1, 2022, under accession number 0001193125-22-207018. biote operates within the healthcare services and wellness sector and remains publicly traded on Nasdaq. Sign up for full data, filings, and analytics on SpacDesk at spacdesk.com.